Moncef Mohamed Slaoui: Leading the Covid-19 Vaccine Team in the US
In today’s world, the name of the terror is Covid-19. The worldwide coronavirus pandemic has forced many countries to commit all their time and money to find the new disease vaccine. Scientific research is yet to bring tangible success.
The highest number of deaths and cases are in the United States. However, the United States is working hard to find a vaccine for preventing the virus. And the team that the country has formed to invent the vaccine has been directed by a Muslim doctor.
In May of 2020, the U.S. President Donald Trump has urged the Muslim-American Moncef Mohamed Slaoui to lead the development of a new coronavirus vaccine (Covid-19). The research on the development of the vaccine is expected to be completed by the end of this year. The Administration of the White House plans to mobilize every opportunity available for prompt American vaccination.
The American of Moroccan origin, Moncef Mohamed Slaoui, was appointed as the chief scientific officer of the project ‘Operation Warp Speed’ to accelerate the development of a vaccine against COVID-19. His research team has already begun researching the vaccine against the new coronavirus.
Who is Dr. Moncef Mohamed Slaoui?
Moncef Mohamed Slaoui was born in 1959. He is a Belgian-American researcher of Moroccan descent.
He spent his childhood in Morocco. A sudden event of that time has completely changed his life. His sister died at an early age of whooping cough. The disease that killed his sister is a kind of immune disease. This incident has inspired him to become a doctor and decided to study immunology.
He went to Europe to study higher education so that no one else died like his sister. At first, he was trying to get admission to some of the universities in France. However, he did not get a chance to study there. He had an opportunity at the University of Brussels after many attempts. There he studied Biology and completed his bachelor’s degree successfully.
Inspired by his studies, Slaoui decided not to stop there and enrolled in graduate school at Harvard Medical University, and at the same time studied at the medical faculty of Tufts University. After graduation, he was awarded a doctorate in molecular microbiology and immunology.
Dr. Slaoui has been chief of the GlaxoSmithKline (GSK) vaccine department for 30 years. He left the company in 2017. Slaoui also left the board of directors for the Moderna biotech firm in Massachusetts. The company has developed a coronavirus vaccine.
U.S. Secretary of Health and Human Services Alex Hazard, named Dr. Slaoui, one of the most experienced and successful vaccine developers in the world. Under his leadership, the Trump administration believes that the United States will be able to invent the vaccine by the end of 2020.
While he works in significant companies worldwide, he is still interested in doing something for ordinary people. He has published his research papers in hundreds of the best scientific journals in the world.